Covered recipient · General Payments record
AMY A JENKINS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,189.12
- Reported across 71 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $312.41 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $168.63 | 10 |
| ABBVIE INC. | $66.50 | 4 |
| Novo Nordisk AS | $24.88 | 1 |
| Phathom Pharmaceuticals, Inc. | $19.85 | 1 |
| Exact Sciences Corporation | $16.98 | 1 |
| Acerta Pharma LLC | $15.57 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.75 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107400040 | CMS |
| ABBVIE INC. | $16.99 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107400042 | CMS |
| ABBVIE INC. | $16.16 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107400044 | CMS |
| ABBVIE INC. | $13.60 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107400046 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.57 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104747349 | CMS |
| Exact Sciences Corporation | $16.98 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114414862 | CMS |
| Lilly USA, LLC | $15.96 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135446675 | CMS |
| Lilly USA, LLC | $17.96 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135525353 | CMS |
| Lilly USA, LLC | $15.63 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135467150 | CMS |
| Lilly USA, LLC | $15.42 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135525351 | CMS |
| Lilly USA, LLC | $15.91 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135506022 | CMS |
| Lilly USA, LLC | $14.76 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135506024 | CMS |
| Lilly USA, LLC | $19.39 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135446673 | CMS |
| Lilly USA, LLC | $20.27 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135530853 | CMS |
| Lilly USA, LLC | $12.29 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135509602 | CMS |
| Lilly USA, LLC | $21.04 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135509600 | CMS |
| Novo Nordisk Inc | $24.88 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100401579 | CMS |
| Phathom Pharmaceuticals, Inc. | $19.85 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151177201 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.